▲ Peaking
Business
Beyond statins, one drug lowered heart attack risk by 20%
Recent coverage examines a real-world study showing Amgen's Repatha lowers heart attack risk by 20% compared to ezetimibe.
Ezetimibe
1 trends tracked about this subject — the full history, oldest to newest below.